PDS Biotech Submits Protocol Amendment for Faster Cancer Drug Approval
PDS Biotechnology updates Phase 3 trial protocol with FDA to potentially speed up approval of PDS0101 for HPV-related head and neck cancer treatment.
/ 907 items
#Healthcare↓
Amazon Pharmacy Now Offers Wegovy Weight-Loss Pill with Affordable Options
Amazon Pharmacy now sells Wegovy weight-loss pill. Insured pay $25/month, uninsured start at $149. Needle-free option available nationwide.
CG Oncology Accelerates Bladder Cancer Trial Results by Nearly a Year
CG Oncology announces earlier-than-expected results for its Phase 3 bladder cancer trial, moving timeline up by nearly one year due to rapid patient enrollment.
uniQure Moves Forward with Huntington's Disease Treatment
uniQure secures FDA meeting to discuss accelerated approval for AMT-130, bringing hope to the Huntington's disease community with potentially life-changing gene therapy.
Aquestive Therapeutics Faces FDA Setback for Anaphylm Drug Approval
Aquestive Therapeutics stock plunges after FDA identifies deficiencies in Anaphylm application, a sublingual film treatment for severe allergic reactions.
Citizens Upgrades Allogene Therapeutics to Outperform
Citizens upgraded Allogene Therapeutics to Outperform with a $5 target, citing improved trial visibility and strong long-term sales potential for cema-cel.